Research area
Breast Cancer biologic therapy trials
Every breast cancer study listed here tests a biologic, such as a vaccine, an antibody, or a cell or gene therapy. Whether you are looking for yourself or for someone you care for, Cancer Biologic Trials can help you find out if a study may be a fit.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Breast cancer biologic therapy studies in numbers
- breast cancer biologic therapy studies recruiting in the U.S.
- 73
- states with a study site
- 51
- studies that accept healthy volunteers
- 2
Source: ClinicalTrials.gov. Data processed .
Breast cancer biologic therapy studies recruiting now
As of November 18, 2026, 73 breast cancer biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.
What they test
- biologics such as vaccines or antibodies69
- medications42
- procedures31
- other approaches11
- genetic approaches4
A study can test more than one.
Main purpose
- treating a condition67
- diagnosis1
- other purposes1
- screening1
Phase
- Early Phase 11
- Phase 126
- Phase 1/210
- Phase 220
- Phase 312
- Phase 41
- No phase1
- Observational2
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other41
- industry24
- government8
Who they enroll
- adults (18 to 64)73
- older adults (65 and over)73
2 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 73 studies.
Recently updated breast cancer biologic therapy studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Aurora, CO · Aventura, FL · Baltimore, MD · and 16 more U.S. locations
- Registry record
- NCT03606967 · updated
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Boston, MA · Columbus, OH · Mineola, NY · and 2 more U.S. locations
- Registry record
- NCT05422794 · updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- ‘Aiea, HI · ‘Ewa Beach, HI · Abilene, TX · and 325 more U.S. locations
- Registry record
- NCT05564377 · updated
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Abilene, TX · Albuquerque, NM · Alexandria, LA · and 69 more U.S. locations
- Registry record
- NCT06393374 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Albuquerque, NM · Altamonte Springs, FL · Athens, GA · and 30 more U.S. locations
- Registry record
- NCT06841354 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Altamonte Springs, FL · Baltimore, MD · Boston, MA · and 53 more U.S. locations
- Registry record
- NCT06966700 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.
Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
What breast cancer biologic therapy studies look at
A vaccine, an antibody, a cell or gene therapy: every breast cancer study listed on Cancer Biologic Trials tests a biologic of that sort. No two of them ask the same things of you. A study is set up to answer a single question, and the visits and tasks involved follow from that question, so they differ between studies.
The biologic under study is investigational in every case. Researchers do not yet have full answers about its risks or about how well it does its job. Finding those answers is the whole reason the study is being run, and that holds whether you are reading for yourself or for someone in your family.
Who may be able to take part
Age, health history, the medications you take now, the way a condition affects you: a study can set requirements on any of these, and each study sets its own. Some also enroll people who do not have the condition at all.
Nobody expects you, or the relative you are reading for, to sort out who fits. That check belongs to the study team, and it takes place during a screening visit. Here is how eligibility and screening work.
What taking part usually involves
A first conversation
Your first conversation is with a coordinator. Nothing else starts until they have described the study in broad outline and you have had your questions answered.
Informed consent
Next comes a written document from the study team. It lays out everything about the study, the risks known so far included. Agreeing or not is up to you.
Screening
Screening for a breast cancer biologic study is a set of health questions and tests. They show whether this study suits you or the person you care for. Some people are screened and still do not go on to take part.
Study visits
Joining a breast cancer biologic study means coming in for planned visits. Those visits let the team follow how your health is doing. Leaving is allowed at any point, and that choice is yours.
Questions about breast cancer biologic therapy studies
Do I need a diagnosis to join a study about breast cancer?
There is no single answer across studies. One may want your diagnosis confirmed beforehand. Another may do its own assessment once you reach screening. The study team will let you know which case is yours.
Would I have to change the care I receive now?
Among breast cancer biologic studies, some let the care you already have continue. Others do not. Please make no changes on your own, whether you are the patient or a family member helping out. Going through this with you is the study doctor's job, and there is room to talk with your regular doctor too before anything is decided.
Is there a cost to take part?
As a rule, participants are not charged for what the study itself involves: the visits, the tests, and the medication being studied. Read more about costs.
Ask about breast cancer biologic therapy studies
Tell us a little about yourself, or about the person you are asking for, and you will hear back from one of our coordinators. An enquiry leaves you free of any obligation.
Independent information
- Breast Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)